Evercore ISI Starts Halozyme Therapeutics (HALO) at Outperform

June 14, 2021 7:25 AM EDT
Get Alerts HALO Hot Sheet
Price: $41.61 +1.14%

Rating Summary:
    15 Buy, 3 Hold, 1 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 16 | Down: 11 | New: 19
Trade Now! 
Join SI Premium – FREE

Evercore ISI initiates coverage on Halozyme Therapeutics (NASDAQ: HALO) with a Outperform rating.


For an analyst ratings summary and ratings history on Halozyme Therapeutics click here. For more ratings news on Halozyme Therapeutics click here.


Shares of Halozyme Therapeutics closed at $42.79 yesterday.


You May Also Be Interested In





Related Categories

New Coverage